2018 Karnataka polls: Congress reduces number of Muslim candidates, fields more Lingayats

coastaldigest.com web desk
April 17, 2018

As predicted by the political observers, the Congress party has reduced the number of Muslim candidates and increased the number of Lingayat candidates for the 2018 Karnataka assembly polls, compared to the 2013 polls.

The Congress, which recently released the list of 218 candidates, has given first priority to Other Backward Classes. As many as 52 OBC candidates have secured place in the list. The Lingayat candidates are second highest in number (48), followed by Vokkaligas (39), SCs (36) and STs (17). Muslims have secured only 15 tickets. The party is yet to announce candidates for six more seats.

Though a recent caste survey has revealed that Karnataka has more Muslim population than Lingayats, the Congress has fielded less Muslim candidates this time. In 2013, there were 19 candidates in the fray. This time their number is only 15.

In 2013, the Congress had fielded 44 candidates from the Lingayat community, including five from the Reddy Lingayats. For the 2018 polls, 48 Lingayat candidates are in the fray, including six from the Reddy Lingayat community.

Comments

Congress has / will rule the country using expert's judgnement and analytical thinking. Although some corruption happened, when it comes public matter; they do care.

 

See other party members, they gave statement whatever comes from their mind, without thinking. They dont care whether it will hurt to any ordinary person or any community.

Naseer mangalore
 - 
Wednesday, 18 Apr 2018

congress thinking Muslims votes are secured to their party, but this is foolishness for them. This election they are understood about who are Muslims and how to treat them on next election.

Imran Mangalore
 - 
Tuesday, 17 Apr 2018

If lingayath don't get ticket, sure they will vote for BJP? 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 4,2020

Hubli, April 3: Twelve people including 5 women as well as 50 unidentified people have been booked for allegedly pelting stones at police personnel in Mantur area of Hubli on Friday.

The police were allegedly attacked for stopping people from offering Friday prayers at a mosque, during the ongoing lockdown put in place in the wake of the coronavirus outbreak.

"12 people including five women and 50 unidentified people have been booked for stone-pelting at police personnel in Mantur area of Hubli today. The women have been taken into custody while police are searching for the others," said Hubli-Dharwad Police Commissioner R Dilip.

The Police Commissioner further said, "Some prominent people of the community had also urged the devotees to go to their homes but they got agitated."

"Four policemen have sustained minor injuries in the incident," he said adding that "legal action will be taken against the culprits." 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 17,2020

Udupi, Jan 17: Six fishermen were rescued by members of another fishing boat after their boat capsized off Gangolli coast in the District recently.

Police on Friday said that the fishing boat, belonging to Jayalakshmi of Kodi Kanyana, had set sail from Malpe towards Gangolli on the night of January 12. On Wednesday (Jan 15) the vessel’s hull got damaged and water began gushing in.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.